Determination of Reference Values for Handgrip Strength and Bioimpedance Values in Healthy Turkish Children

NCT ID: NCT06001931

Last Updated: 2023-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-01

Study Completion Date

2023-09-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, our aim is to determine the reference values for the handgrip force and bioimpedance values in healthy Turkish children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, our aim is to determine the reference values for the handgrip force and bioimpedance values in healthy Turkish children.

The study was planned as a cross-sectional clinical study. All healthy children studying at Hamdi Akverdi Primary School and Halil Bedii Management Secondary School in the Bakırköy region of Istanbul will be included. The date of birth of the children will be learned. It will be determined in which city in Turkey the population is registered.

TANITA BIA analysis and hand grip strength (with jamar) measured in the dominant hand were planned for all children. In addition, the calf circumference of all children will be measured. Written consent forms will be obtained from the families of the children before the evaluation.

It was planned to include 1500 children in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia Child Development

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

handgrip force and bioimpedance values in healthy Turkish children.

Demographic characteristics, calf circumference , Hand grip strength , TANITA BIA analysis

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy children
* Children under 18
* Turkish children

Exclusion Criteria

* Children with malignancy or known chronic disease
Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tuğba Aydın

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

TUGBA AYDIN

Role: PRINCIPAL_INVESTIGATOR

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tugba Aydin

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Liu J, Yan Y, Xi B, Huang G, Mi J; China Child and Adolescent Cardiovascular Health (CCACH) Study Group. Skeletal muscle reference for Chinese children and adolescents. J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):155-164. doi: 10.1002/jcsm.12361. Epub 2018 Nov 30.

Reference Type BACKGROUND
PMID: 30499245 (View on PubMed)

McCarthy HD, Samani-Radia D, Jebb SA, Prentice AM. Skeletal muscle mass reference curves for children and adolescents. Pediatr Obes. 2014 Aug;9(4):249-59. doi: 10.1111/j.2047-6310.2013.00168.x. Epub 2013 Jun 18.

Reference Type BACKGROUND
PMID: 23776133 (View on PubMed)

Rauch F, Neu CM, Wassmer G, Beck B, Rieger-Wettengl G, Rietschel E, Manz F, Schoenau E. Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics. Pediatr Res. 2002 Apr;51(4):505-10. doi: 10.1203/00006450-200204000-00017.

Reference Type BACKGROUND
PMID: 11919337 (View on PubMed)

Molenaar HM, Selles RW, Zuidam JM, Willemsen SP, Stam HJ, Hovius SE. Growth diagrams for grip strength in children. Clin Orthop Relat Res. 2010 Jan;468(1):217-23. doi: 10.1007/s11999-009-0881-z. Epub 2009 May 21.

Reference Type BACKGROUND
PMID: 19459024 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IstanbulPMRTRHChldBioimpedans

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.